Cabecera

Call Type: JOB OFFERS

Call Info

24-067_MS_MB International Project Manager - Infections and Cancer

Application Submission process

From: 28/05/2024 00:00 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris

To: 11/06/2024 23:59 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris

Info:

 

International Project Manager - Infections and Cancer

Ref.: 24-067_MS_MB

 

About the research group

The Unit of Information and Interventions in Infections and Cancer (UNIC II) has long-standing expertise in the prevention of HPV infections and cervical cancer. It facilitates information for decision-making bodies and enables public health interventions both nationally and internationally. UNIC II is recognized for conducting high-quality research to improve the prevention of cancers associated with HPV infection.

The European Partnership to Contrast HPV (PERCH) is a European Union-funded project that will involve 17 European countries. The general objective of PERCH is to contribute to the implementation of Europe’s Beating Cancer Plan, which aims to support Member States’ efforts to extend the roll-out of routine HPV vaccination to eliminate cervical cancer and other cancers caused by HPV in the coming decade. PERCH begins with an analysis of how HPV vaccination and screening are implemented and monitored in all participating countries. It will then analyze determinants of vaccination hesitation to increase knowledge and awareness, targeting populations on the benefits of vaccine uptake. Training activities will also be provided for health personnel on vaccination communication. Finally, before the end of the Joint Action (JA), Member States will be supported to launch large-scale HPV vaccination campaigns.

 

About the role

To primarily perform tasks related to international project management (PERCH), particularly to:

  • Support the Principal Investigator (PI) and coordinate the tasks of the researchers at UNIC II, as well as the leaders of the Work Package (WP) and national coordinators of the PERCH project.
  • Monitor the participation of UNIC II in the development of various WPs, working directly with the WP leaders of the PERCH project.
  • Prepare follow-up and deliverable reports for WP3-Evaluation according to the PERCH Project Schedule.
  • Prepare for and attend PERCH online and face-to-face coordination meetings.
  • Collaborate in the preparation of scientific reports for the PERCH project in coordination with the researchers at UNIC II.
  • Participate in obtaining, interpreting, and disseminating the results of the PERCH project.

 

Job requirements

Professional experience

  • Researcher and/or project manager in health-related research projects


Education and Training

  • Master's degree in a field related to public health, health policy, clinical research, or global health


Technical & Soft Skills

  • Advanced proficiency in MS Office Suite: Word, Excel, PowerPoint, and Teams
  • Exceptional ability to collaborate effectively in both team and independent settings
  • Strong expertise in managing scientific projects.


Languages

  • Fluent in English and proficient in Spanish/Catalan languages

 

We will value, but not require
  • PhD holder 
  • Bachelor's degree in Health Sciences
  • Research and/or project management expertise in European Commission-funded projects
  • Experience in evaluating Joint Actions or health interventions

 

 

What do we offer

  • No. of positions: 1

  • Estimated start date: 20/06/2024

  • Contract duration: Permanent linked to projects

  • Estimated annual gross salary: 27.000 € - 31.000 €

  • You will be part of a multicultural team. We have a fun loving and friendly international work environment.

  • Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.

  • Possibility to work some days in remote - Teleworking

  • 26 working days of holiday per year

  • System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.

  • Paid leave package

  • Benefits of constant training are offered

  • We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.

 

Deadline: Please submit your application by 11/06/2024 

 

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate.

You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

 

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

 

Observations

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).

The contract resulting from this offer has been funded by the European Union’s EU4Health Programme (2021-2027) under the Joint Action 101075314. We thank CERCA Programme/Generalitat de Catalunya for institutional support.

 

 

   

Documentation

Call Document